Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition

Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition

Bibliographic Details
Main Authors: Pepper, C, Buggins, A G S, Jones, C H, Walsby, E J, Forconi, F, Pratt, G, Devereux, S, Stevenson, F K, Fegan, C
Format: Online
Language:English
Published: Nature Publishing Group 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360209/
id pubmed-4360209
recordtype oai_dc
spelling pubmed-43602092015-03-17 Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition Pepper, C Buggins, A G S Jones, C H Walsby, E J Forconi, F Pratt, G Devereux, S Stevenson, F K Fegan, C Letter to the Editor Nature Publishing Group 2015-03 2014-11-18 /pmc/articles/PMC4360209/ /pubmed/25349153 http://dx.doi.org/10.1038/leu.2014.308 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Pepper, C
Buggins, A G S
Jones, C H
Walsby, E J
Forconi, F
Pratt, G
Devereux, S
Stevenson, F K
Fegan, C
spellingShingle Pepper, C
Buggins, A G S
Jones, C H
Walsby, E J
Forconi, F
Pratt, G
Devereux, S
Stevenson, F K
Fegan, C
Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition
author_facet Pepper, C
Buggins, A G S
Jones, C H
Walsby, E J
Forconi, F
Pratt, G
Devereux, S
Stevenson, F K
Fegan, C
author_sort Pepper, C
title Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition
title_short Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition
title_full Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition
title_fullStr Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition
title_full_unstemmed Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition
title_sort phenotypic heterogeneity in ighv-mutated cll patients has prognostic impact and identifies a subset with increased sensitivity to btk and pi3kδ inhibition
description
publisher Nature Publishing Group
publishDate 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360209/
_version_ 1613198863507652608

Similar Items